Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intercure Ltd (NQ: INCR )

1.360 +0.020 (+1.50%)
Streaming Delayed Price Updated: 2:42 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,161
Open 1.360
Bid (Size) 1.350 (5)
Ask (Size) 1.370 (1)
Prev. Close 1.340
Today's Range 1.318 - 1.370
52wk Range 1.100 - 3.720
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A. 
Via Benzinga
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+4.31%
+4.31%
1 Month
-22.72%
-22.72%
3 Month
-33.33%
-33.33%
6 Month
-56.48%
-56.48%
1 Year
+21.44%
+21.44%

More News

Read More
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
From InterCure
Via Business Wire
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon
Via Benzinga
Topics Cannabis
Exposures Cannabis
5 Value Stocks In The Healthcare Sector
Via Benzinga
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
Via Benzinga
Topics Cannabis
Exposures Cannabis
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
From InterCure Ltd.
Via Business Wire
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
Via Benzinga
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
From InterCure Ltd.
Via Business Wire
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict
Via Benzinga
Topics Cannabis
Exposures Cannabis
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
From InterCure Ltd.
Via Business Wire
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
From InterCure Ltd.
Via Business Wire
Canndoc Reports Record Revenue Amid Cannabis Market Turmoil
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For August 18, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Medical Cannabis Company Better Is Suing InterCure For $35M
Via Benzinga
InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details
Via Benzinga
Marijuana Stock Movers For August 9, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Are Cannabis Stocks Trading Higher Today?
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
Cannabis Stock Movers For July 24, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.